Address: st. Mechnikov, 3
01113 Kiev, Ukraine
Tel: +38 (044) 390-52-70
‘Unipharm, INC.’ is a young but rapidly expanding American pharmaceutical company. It was founded in 1992 and today has eight offices worldwide and its staff consists of more than 300 highly qualified employees.
The young age of the company is its great advantage. From the very beginning, Unipharm applied up-to-date technology with a modern organization and dynamic market methods to expand across Europe and the world. Unipharm focuses on innovative ideas and enthusiasm of its young professionals.
The results achieved confirm that Unipharm’s marketing strategy and basic tactical development lines are correct. Today, Unipharm is already number one in sales of vitamin and mineral drugs in Ukraine and Russia with significant increases of its market share in other ex-Soviet countries.
The company’s products are – both in terms of quality and price – competitive with the products of companies that have been present in the global pharmaceutical market for many decades. Unipharm does not only extend its product portfolio but also develops new markets, especially those where there is a need for our products.
The biggest success of the company is associated with the VITRUM ® brand – the original modern combinations of vitamins and minerals. The high quality and efficacy of VITRUM ®, confirmed by numerous laboratory and clinical research, ensured the success of the company not only in Ukraine but also in many other countries all over the world.
You recently switched from Novartis to Unipharm. Given the major differences in environment and portfolio, what was it about Unipharm in particular that attracted you and what are you bringing…
Dr. Natalya Gudz, head of the State Service of Ukraine on Medicines and Drugs Control (SMDC), provides her vision for the development of Ukraine’s key regulatory authority and the win-win…
Denis Shevchenko, founder of the NGO and charitable foundation PharmVarta, provides insights into the main initiatives of this independent, non-profit organization that has freely supplied Ukrainian patients with more than…
Alexander Markus, chairman of the board of the recently set up German-Ukrainian Chamber of Industry and Commerce, provides insights into the new dynamics driving the growth of Ukraine’s foreign trade…
Dr. Volodymyr Redko, executive director of Ukraine’s Association of Pharmaceutical Research and Development (APRaD), which gathers together 15 international R&D-driven companies, provides insights into the perspective of international innovators vis-à-vis…
As the first Ukrainian pharmaceutical company backed by foreign capital, explain to us how the idea of creating “Sperco Ukraine” as a joint-venture with UCRAFARMA emerged? The idea to create…
As a leader responsible for heading Roche’s operations since its establishment of an LLC in Ukraine in 2009, what do you consider have been the main achievements of the company?…
Nobel Pharma has quite a history in the CIS region as this region is becoming increasingly important for the company. What is the company’s story in Ukraine? Nobel Pharma Ukraine…
Let us start with the history of InterChem which is quite unique and started as a chemical company with a very small group from the National Academy of Sciences. Please…
It has been almost a decade since Mili Healthcare began its operations in Ukraine today becoming one of the top 20 leading foreign companies in the local industry. What were…
What was the vision behind the creation of APRaD back in 2007 and what was lacking in the market at that time that called for such an association? APRaD originated…
You recently switched from Novartis to Unipharm. Given the major differences in environment and portfolio, what was it about Unipharm in particular that attracted you and what are you bringing…
Since 2006 Teva has been on a solid phase of growth and consolidation, mainly through the acquisitions of IVAX in 2006, Pliva (Barr) in 2008 and ratiopharm in 2010, which…
See our Cookie Privacy Policy Here
